Oral Manifestations of Autoimmune Blistering Diseases

Which oral findings should raise suspicion?

Autoimmune blistering diseases develop when an immune response attacks proteins that hold epithelial cells together or attach the epithelium to underlying tissue. The epithelium is the surface lining of the mouth. Its separation produces blisters that frequently rupture before examination.

A bulla is a large fluid-filled blister; an erosion is a shallow loss of surface lining. Oral disease may precede visible skin disease, so a normal skin examination does not exclude an autoimmune cause. Persistent multifocal erosions deserve particular attention.

Desquamative gingivitis means red, peeling or easily bleeding gingiva. It is a clinical description, not a diagnosis, and may reflect autoimmune blistering disease or another inflammatory disorder.

• ·Painful, irregular erosions affecting several oral sites, sometimes with loose epithelial edges.
• ·Gingival soreness and peeling that are disproportionate to visible plaque.
• ·Blisters reported by the patient but absent during examination.
• ·Fragile mucosa that separates after minor friction or routine dental manipulation.
• ·Oral lesions accompanied by eye irritation, skin blisters, genital symptoms, hoarseness or swallowing difficulty.

Which diseases cause these oral patterns?

Pemphigus vulgaris often produces persistent, painful oral erosions because its blisters are fragile. The cheeks, palate, lips, tongue and gingiva may be affected. Oral lesions can appear before skin lesions and usually heal without substantial scarring.

Mucous membrane pemphigoid predominantly affects mucosal surfaces. Gingival disease is common, and relatively intact blisters may occasionally be visible. Oral severity does not reliably indicate the severity of disease elsewhere; ocular or airway involvement can scar and threaten function.

• ·Bullous pemphigoid: usually dominated by skin disease. Oral involvement can occur, but extensive oral-predominant disease should prompt consideration of other diagnoses.
• ·Paraneoplastic pemphigus: severe, persistent inflammation and erosion of the mouth and lips, sometimes with varied skin lesions. Its association with an underlying tumour warrants coordinated dermatology and medical assessment.
• ·Linear IgA disease: a disorder involving immunoglobulin A, an immune protein. Oral findings can resemble pemphigoid, making laboratory distinction important.
• ·Epidermolysis bullosa acquisita: an acquired autoimmune disorder that can cause trauma-related blistering, mucosal disease and scarring.
• ·Bullous lupus: blistering associated with systemic lupus, a multisystem autoimmune condition. Consider it when the wider medical history supports that possibility.

What belongs in the differential diagnosis?

The appearance of an erosion alone rarely establishes its cause. Distribution, recurrence, associated white changes, systemic symptoms and tissue findings should guide the differential diagnosis. Avoid labelling every peeling gingival lesion as pemphigoid.

A positive Nikolsky sign means gentle mechanical pressure causes epithelial separation. It supports mucosal fragility but is not specific to one disease. Repeatedly provoking it causes unnecessary trauma and does not replace biopsy.

• ·Erosive oral lichen planus: look for accompanying white, lace-like lines and bilateral disease. Some cases remain difficult to distinguish clinically.
• ·Traumatic or contact-related injury: look for a local mechanical cause, recent dental intervention or relevant exposure pattern.
• ·Recurrent aphthous ulceration: usually causes discrete episodes of ulcers rather than widespread epithelial peeling.
• ·Infection: consider an acute onset, systemic illness, immune impairment or characteristic lesion distribution. Infection can also complicate autoimmune disease.
• ·Acute mucocutaneous reactions: sudden extensive oral disease with fever, skin lesions or eye involvement needs urgent hospital assessment.
• ·Oral malignancy: a persistent focal ulcer, firm area, mass or unexplained bleeding requires assessment independently of any autoimmune diagnosis.

What examination sequence is useful?

Begin by assessing breathing, swallowing, hydration and general condition. Ask about eye symptoms before undertaking a detailed dental examination. Photographs and a lesion map help document disease without repeatedly manipulating fragile tissue.

Persistent or recurrent peeling and erosions require an in-person examination. Remote review can support triage or follow-up but cannot assess tissue firmness, examine all mucosal sites or obtain diagnostic tissue.

• ·History: establish onset, progression, recurrence, pain, bleeding, eating limitations, weight change and previous investigations.
• ·Exposure review: document current and recently introduced prescribed treatments, dental materials and oral-care products without assuming causation.
• ·Extraoral examination: inspect accessible skin and lips, assess cervical lymph nodes, and record facial or neck swelling.
• ·Oral examination: gently inspect every oral surface, including gingiva, palate, tongue, floor of mouth and posterior regions where accessible.
• ·Lesion description: record erosion distribution, intact blisters, white striae, scarring, focal firmness and local traumatic factors.
• ·Multisite screening: ask about gritty or red eyes, light sensitivity, visual change, nasal crusting, hoarseness, swallowing pain and genital symptoms.
• ·Functional assessment: document mouth opening, oral intake and ability to maintain oral hygiene.

When should an oral lesion be biopsied, and from where?

Arrange biopsy when autoimmune blistering disease is suspected from persistent erosions, unexplained desquamative gingivitis or recurrent mucosal blistering. Do not wait for skin lesions or an intact oral blister. If suitable sampling or specimen handling is unavailable, refer to oral medicine or dermatology rather than taking a poorly planned sample.

Diagnosis commonly requires separate specimens for routine histology and direct immunofluorescence, or DIF. Histology examines tissue structure. DIF detects immune deposits within tissue and needs handling that differs from routine histology.

• ·For routine histology, select a fresh lesion edge that includes preserved epithelium and adjacent connective tissue. An ulcer centre alone often yields nonspecific inflammation.
• ·For DIF, sample intact tissue near a lesion rather than the eroded base. In suspected mucous membrane pemphigoid, normal-appearing buccal mucosa can also be diagnostically useful when selected appropriately.
• ·Coordinate with the receiving laboratory before biopsy. Confirm the required transport medium, container and delivery arrangements.
• ·Keep the DIF specimen separate from the routine histology specimen. Routine histology fixation can make tissue unsuitable for standard DIF assessment.
• ·Label each site and specimen purpose clearly. Provide the clinical differential, disease distribution and relevant treatment history.

How should histology, DIF and blood tests be interpreted?

Pemphigus typically shows acantholysis, meaning loss of adhesion between epithelial cells. Pemphigus vulgaris often produces a split just above the basal cell layer. DIF usually demonstrates immune deposits between epithelial cells.

Pemphigoid-spectrum disorders generally produce a split beneath the epithelium. DIF often shows linear deposits along the basement membrane zone, the interface between epithelium and underlying tissue. This pattern supports a disease group but does not by itself identify every subtype.

Specialist laboratories may use indirect immunofluorescence, which tests circulating antibodies, and assays directed at specific target proteins. Salt-split testing uses laboratory-separated tissue to help locate antibody binding. These tests refine the diagnosis rather than replacing clinical assessment and tissue examination.

• ·A negative DIF result does not exclude disease when clinical suspicion remains strong.
• ·Review specimen site, epithelial preservation, transport, processing and prior treatment before accepting a negative result.
• ·Seek clinicopathological review and consider repeat or alternative-site sampling through the specialist team.
• ·Negative blood antibody tests do not reliably exclude mucous membrane pemphigoid.
• ·When pathology and clinical findings disagree, reassess the diagnosis rather than relying on one isolated result.

When are imaging or other investigations indicated?

Routine dental radiographs, cone-beam computed tomography and magnetic resonance imaging do not diagnose autoimmune epithelial blistering. Oral mucosal disease alone is not an indication for these scans. Clinical examination, histology and immunopathology remain central.

Investigations should address a specific competing diagnosis, complication or affected organ. A suspicious neck node, deep swelling, focal numbness or possible bone involvement requires a separate diagnostic pathway rather than attribution to superficial mucosal disease.

• ·Use dental imaging when examination suggests an accompanying dental or jaw disorder.
• ·Refer airway symptoms to ear, nose and throat services for appropriate assessment, which may include direct visual examination.
• ·Persistent swallowing symptoms may require gastroenterology assessment and selected endoscopic investigation.
• ·Suspected paraneoplastic pemphigus warrants specialist-directed assessment for an associated tumour; avoid indiscriminate imaging based only on oral erosions.
• ·Systemic investigations should reflect the suspected disorder, nutritional impact, associated illness and planned specialist care.

Exactly when and where should the patient be referred?

Referral urgency depends on organ risk and functional impairment, not simply the area of oral erosion. The thresholds below are practical clinical triage guidance, not universal appointment deadlines quoted from a single guideline. Do not delay emergency assessment while awaiting biopsy results.

For suspected or confirmed mucous membrane pemphigoid, arrange ophthalmology assessment even when eye symptoms are absent. Early ocular disease may be subtle. An oral examination cannot exclude conjunctival inflammation or scarring.

• ·Immediate emergency department assessment: breathing difficulty, noisy breathing, inability to swallow saliva, rapidly worsening throat symptoms, severe dehydration or extensive blistering with systemic illness. Airway concerns require emergency ear, nose and throat support.
• ·Same-day urgent ophthalmology assessment: red or painful eyes, light sensitivity, visual change or new persistent gritty irritation in a patient with suspected mucous membrane pemphigoid. Use an emergency eye service if direct review is unavailable.
• ·Urgent ear, nose and throat referral: persistent hoarseness, suspected laryngeal involvement or progressive upper-airway symptoms without current respiratory distress. Escalate immediately if breathing becomes affected.
• ·Urgent medical or gastroenterology assessment: progressive swallowing difficulty, painful swallowing or reduced intake. Inability to manage fluids or saliva warrants emergency assessment.
• ·Prompt oral medicine and dermatology referral: unexplained multifocal erosions, recurrent blistering or desquamative gingivitis requiring tissue diagnosis and coordinated care.
• ·Urgent oral medicine, oral and maxillofacial surgery or head-and-neck cancer assessment: a non-healing ulcer beyond two weeks, a lump, numbness, unexplained bleeding or difficulty opening the mouth. Swallowing difficulty also requires assessment, with urgency determined by severity.

What should the referral contain?

A useful referral makes the suspected diagnosis, organ risks and immediate clinical problem clear. State explicitly whether eye, airway and swallowing symptoms were asked about. If an urgent referral is required, communicate directly with the receiving service rather than relying only on a routine booking request.

In Mumbai, Thane, Ambarnath and neighbouring areas, choose services according to available oral medicine, dermatology, ophthalmology and airway expertise. Convenience should not delay transfer to a hospital capable of managing organ-threatening disease.

• ·Symptom timeline, affected sites, functional impact and any weight loss.
• ·Clinical photographs, with consent, and a clear lesion map.
• ·Relevant medical history, current treatment history and previous diagnostic labels.
• ·Biopsy reports, specimen sites, DIF results and available antibody testing.
• ·Specific red flags and the reason for the requested urgency.
• ·A named clinician or service responsible for reviewing pending results and contacting the patient.

What does treatment involve, and who should deliver it?

Treatment aims to control immune-mediated injury, reduce discomfort, preserve nutrition and prevent scarring at vulnerable sites. Oral medicine and dermatology should coordinate disease-directed care. Treatment selection depends on the diagnosis, extent of disease and involvement of the eyes, airway or other organs.

Broad options include local anti-inflammatory care for selected limited disease and systemic immune-modifying care for more extensive or high-risk disease. Specialist-led advanced immune therapy may be considered in selected cases. These decisions require diagnostic confirmation, risk assessment and monitoring.

• ·Dentists provide gentle plaque control, address traumatic dental factors and adapt procedures to mucosal fragility.
• ·Ophthalmology directs ocular management and surveillance for scarring.
• ·Ear, nose and throat specialists manage laryngeal or upper-airway involvement.
• ·Gastroenterology, nutrition services and other specialties support swallowing, intake and additional organ involvement.
• ·Defer elective procedures that would traumatise actively inflamed mucosa, while addressing urgent dental disease through coordinated care.
• ·Follow-up should reassess oral activity, function, new extraoral symptoms and any focal lesion that behaves differently from the surrounding disease.

Which guideline-level sources support this approach?

The European Academy of Dermatology and Venereology S3 guideline on diagnosis and management of mucous membrane pemphigoid, Parts I and II, published in the Journal of the European Academy of Dermatology and Venereology in 2021, supports integrated clinical and immunopathological diagnosis. It also emphasises assessment of affected organs and multidisciplinary management of sites where scarring threatens function.

The international expert-panel recommendations, “Diagnosis and management of pemphigus,” published in the Journal of the American Academy of Dermatology in 2020, support combining clinical findings, histology, DIF and appropriate serological testing. They also support specialist assessment of disease extent and treatment planning.

The practical implications are to obtain suitable tissue, interpret negative tests cautiously when suspicion remains high, and identify ocular or airway risk early. Laboratory-specific specimen requirements and local referral arrangements should be confirmed directly. This article addresses recognition and referral, not a prescribing protocol.